Targeted liposomes encapsulated iridium(III) compound greatly enhance anticancer efficacy and induce cell death via ferroptosis on HepG2 cells
作者:Jing Chen、Wenlong Li、Gechang Li、Xiaoming Liu、Chunxia Huang、Hua Nie、Lijuan Liang、Yi Wang、Yunjun Liu
DOI:10.1016/j.ejmech.2023.116078
日期:2024.2
2-phenyl-1H-imidazo[4,5-f][1,10]phenanthroline (PIP), 2-(2-nitrophenyl)-1H-imidazo[4,5-f][1,10]phenanthroline (NPIP), 2-(2-nitronaphthalen-1-yl)-1H-imidazo[4,5-f][1,10]phenanthroline (NNIP) and their iridium(III) metal compounds [Ir(ppy)2(PIP)](PF6) (ppy = 2-phenylpyridine, 1a), [Ir(ppy)2(NPIP)](PF6) (1b), [Ir(ppy)2(NNIP)](PF6) (1c) were designed and synthesized. The anti-cancer activities of 1a, 1b and
在本研究中,配体 2-苯基-1H-咪唑并[4,5-f][1,10]菲咯啉 (PIP)、2-(2-硝基苯基)-1H-咪唑并[4,5-f][1、 10]菲咯啉 (NPIP)、2-(2-硝基萘-1-基)-1H-咪唑并[4,5-f][1,10]菲咯啉 (NNIP) 及其铱(III)金属化合物 [Ir(ppy) ) 2 (PIP)](PF 6 ) (ppy = 2-苯基吡啶, 1a), [Ir(ppy) 2 (NPIP)](PF 6 ) (1b), [Ir(ppy) 2 (NNIP)](PF 6 ) (1c) 被设计和合成。采用MTT法检测1a、1b和1c对BEL-7402、HepG2、SK-Hep1和非癌LO2的抗癌活性。 1a显示中等抗癌活性,1b和1c显示低抗癌活性或无抗癌活性。为了提高抗癌效果,将化合物1a、1b和1c封装到普通或靶向脂质体中,制成1alip、1blip、1clip或靶向1aTlip、1bTlip和1cTlip。